Rchr

J-GLOBAL ID：201801013149409745 Update date: Sep. 01, 2020

Tamami Morisaki

Tamami Morisaki

Affiliation and department：
Papers (10)：

Tanaka F, Tominaga K, Fujikawa Y, Morisaki T, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Nakano A, et al. Association between Functional Dyspepsia and Gastric Depressive Erosions in Japanese Subjects. Internal medicine (Tokyo, Japan). 2018
Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Morisaki T, Takashima T, Tomita S, Hirakawa K, Ohira M. Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer. Journal of cancer research and clinical oncology. 2018. 144. 8. 1547-1559
Kasashima H, Yashiro M, Okuno T, Miki Y, Kitayama K, Masuda G, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T, et al. Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer. Digestion. 2018. 98. 4. 238-248
Wataru Goto, Shinichiro Kashiwagi, Yuka Asano, Koji Takada, Tamami Morisaki, Hisakazu Fujita, Tsutomu Takashima, Masahiko Ohsawa, Kosei Hirakawa, Masaichi Ohira. Eribulin promotes antitumor immune responses in patients with locally advanced or metastatic breast cancer. Anticancer Research. 2018. 38. 5. 2929-2938
Yuka Asano, Shinichiro Kashiwagi, Wataru Goto, Koji Takada, Katsuyuki Takahashi, Tamami Morisaki, Hisakazu Fujita, Tsutomu Takashima, Shuhei Tomita, Masahiko Ohsawa, et al. Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression. Journal of Translational Medicine. 2018. 16. 1. 87

ｍore...

MISC (15)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP